64 related articles for article (PubMed ID: 30147305)
1. Measuring the Influence of Side Effect Expectations, Beliefs, and Incident Side Effects on the Risk for Drug Discontinuation Among Individuals Starting New Medications, a Cross-sectional Study.
Blackburn DF; Yao S; Taylor JG; Alefan Q; Lix LM; Eurich DT; Choudhry NK
Patient Prefer Adherence; 2024; 18():979-989. PubMed ID: 38774475
[TBL] [Abstract][Full Text] [Related]
2. Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia.
Lam T; Biggs N; Xia T; Evans J; Stevens J; da Gama M; Lubman DI; Nielsen S
BMJ Open; 2022 Apr; 12(4):e060151. PubMed ID: 35418442
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life.
Al-Musawe L; Torre C; Guerreiro JP; Rodrigues AT; Raposo JF; Mota-Filipe H; Martins AP
Pharmacol Res Perspect; 2020 Aug; 8(4):e00621. PubMed ID: 32618136
[TBL] [Abstract][Full Text] [Related]
4. Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data.
Wei W; Gruebner O; von Wyl V; Dressel H; Ulyte A; Brüngger B; Blozik E; Bähler C; Braun J; Schwenkglenks M
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32094222
[TBL] [Abstract][Full Text] [Related]
5. Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review.
Boye KS; Shinde S; Kennedy-Martin T; Robinson S; Thieu VT
Patient Prefer Adherence; 2022; 16():23-39. PubMed ID: 35023906
[TBL] [Abstract][Full Text] [Related]
6. Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal.
Torre C; Guerreiro J; Longo P; Raposo JF; Leufkens H; Martins AP
Patient Prefer Adherence; 2018; 12():1471-1482. PubMed ID: 30147305
[TBL] [Abstract][Full Text] [Related]
7. Low persistence with oral biphosphonate treatment in postmenopausal osteoporosis.
Torre C; Guerreiro J; Mendes Z; Miranda A; Bragança F; Cristino J; Canhão H; Branco JC
Acta Reumatol Port; 2019; 44(2):114-125. PubMed ID: 31280276
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in adults with type 2 diabetes mellitus starting with new glucose lowering drugs: An inception cohort study.
Torre C; Guerreiro J; Longo P; Raposo JF; Leufkens H; Martins AP
Prim Care Diabetes; 2019 Jun; 13(3):221-232. PubMed ID: 30573348
[TBL] [Abstract][Full Text] [Related]
9. Intensive monitoring of adverse drug events associated with the use of new glucose-lowering drugs: results from an inception cohort study in Portugal.
Torre C; Guerreiro J; Longo P; Raposo JF; Leufkens H; Martins AP
Diabet Med; 2020 Apr; 37(4):648-656. PubMed ID: 31692117
[TBL] [Abstract][Full Text] [Related]
10. Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 May; 5(5):532-539. PubMed ID: 32129795
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
[TBL] [Abstract][Full Text] [Related]
12. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
Cho NH; Shaw JE; Karuranga S; Huang Y; da Rocha Fernandes JD; Ohlrogge AW; Malanda B
Diabetes Res Clin Pract; 2018 Apr; 138():271-281. PubMed ID: 29496507
[TBL] [Abstract][Full Text] [Related]
13. Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States.
Cai J; Divino V; Burudpakdee C
Curr Med Res Opin; 2017 Jul; 33(7):1317-1328. PubMed ID: 28418262
[TBL] [Abstract][Full Text] [Related]
14. Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia.
Zongo FE; Moisan J; Grégoire JP; Lesage A; Dossa AR; Lauzier S
Res Social Adm Pharm; 2018 Jan; 14(1):53-61. PubMed ID: 28077240
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
